about
Crystallographic Complexes of Surfactant Protein A and Carbohydrates Reveal Ligand-induced Conformational ChangeElucidation of Lipid Binding Sites on Lung Surfactant Protein A Using X-ray Crystallography, Mutagenesis, and Molecular Dynamics SimulationsSP-R210 (Myo18A) Isoforms as Intrinsic Modulators of Macrophage Priming and ActivationMutagenesis of surfactant protein D informed by evolution and x-ray crystallography enhances defenses against influenza A virus in vivoNew concepts in collectin-mediated host defense at the air-liquid interface of the lung.The flagellum of Pseudomonas aeruginosa is required for resistance to clearance by surfactant protein A.Diffuse Cystic Lung Disease. Part I.Diffuse Cystic Lung Disease. Part II.Diffuse Cystic Lung Disease as the Presenting Manifestation of Sjögren SyndromeClinical trials for rare lung diseases: lessons from lymphangioleiomyomatosis.Domains of surfactant protein A that affect protein oligomerization, lipid structure and surface tension.Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trialModeling pulmonary alveolar microlithiasis by epithelial deletion of the Npt2b sodium phosphate cotransporter reveals putative biomarkers and strategies for treatment.Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications.Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism.Diagnosis and Treatment of Lymphatic Plastic Bronchitis in Adults Using Advanced Lymphatic Imaging and Percutaneous Embolization.Lymphangioleiomyomatosis: a clinical update.Keratinocyte growth factor augments pulmonary innate immunity through epithelium-driven, GM-CSF-dependent paracrine activation of alveolar macrophagesKeratinocyte growth factor administration attenuates murine pulmonary mycobacterium tuberculosis infection through granulocyte-macrophage colony-stimulating factor (GM-CSF)-dependent macrophage activation and phagolysosome fusionUtility of [18F]2-fluoro-2-deoxyglucose-PET in sporadic and tuberous sclerosis-associated lymphangioleiomyomatosis.Pulmonary manifestations of Birt-Hogg-Dubé syndrome.Air travel in women with lymphangioleiomyomatosis.Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphansLymphangioleiomyomatosis - a wolf in sheep's clothing.The alveolar epithelium determines susceptibility to lung fibrosis in Hermansky-Pudlak syndrome.Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasmKeratinocyte growth factor supports pulmonary innate immune defense through maintenance of alveolar antimicrobial protein levels and macrophage function.The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment.A Novel Quantitative Computed Tomographic Analysis Suggests How Sirolimus Stabilizes Progressive Air Trapping in Lymphangioleiomyomatosis.Diagnostic potential of serum VEGF-D for lymphangioleiomyomatosis.Oral administration of surfactant protein-a reduces pathology in an experimental model of necrotizing enterocolitis.Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis.Interactions of pulmonary collectins with Bordetella bronchiseptica and Bordetella pertussis lipopolysaccharide elucidate the structural basis of their antimicrobial activitiesReview: Structural determinants of pattern recognition by lung collectins.Lymphangioleiomyomatosis: new concepts in pathogenesis, diagnosis, and treatment.Lymphangioleiomyomatosis screening in women with tuberous sclerosis.Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry.A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis.Nonmalignant Adult Thoracic Lymphatic Disorders.Chest Computed Tomographic Image Screening for Cystic Lung Diseases in Patients with Spontaneous Pneumothorax Is Cost Effective.
P50
Q27665573-47326635-6085-4939-A7CB-F4CB6F133476Q27712375-A9602D59-0675-48F8-AC25-830A870ED972Q28116165-33CB7124-D34B-41B8-A663-6FC1DD0E32F1Q30407670-DBD1BBEC-E5A1-4FB6-BE33-714C3F06AFCBQ33232071-3904031D-95AC-41C2-84C4-B2B31767202AQ33288960-761AF20A-4B3B-4BAC-BC29-533CDA0AE8E8Q33722950-8DB52D06-F1F0-48FB-9EF2-90F40C408373Q33735622-E77A6732-4C61-4174-8727-4C378D9B581AQ33772431-E227738E-85B7-401D-A9FF-EEF51D580807Q33905175-FD5065BE-17FD-4FC1-B1F0-64A7537B6801Q34258886-B6ED15C0-EA76-4A02-A75B-335F2DA1A6A1Q34380247-4507793D-0B16-4DBC-A771-9B94BF055C2DQ34501455-0599CD82-BA5C-407C-ADEB-D7A026C5215DQ34523608-8DB4F7BD-31FF-4426-A3D5-B1E74289CA75Q34528572-E1069DA3-7F2A-4204-A630-934DB46F7F0AQ34539548-DC35BA85-66AF-4918-BC9A-7FDC7F292998Q34746692-68F18FC0-89F4-442C-95BA-94739A5772C5Q34869806-A05F8167-DBCA-48B2-ACB9-E5907EBF2277Q35172678-5BF42E0C-0002-4238-941F-EAA4D583C9ACQ35410898-B1848247-A890-4A4A-9AC7-AC93B0710F7BQ35536837-38C0234C-C8EB-454F-A7FB-B0BADE32BEAFQ36203236-8D8C30E5-0FAD-41DC-91EC-F660E6AB48C9Q36330644-12D487FD-BF5B-4CA7-9298-525C56C4B46BQ36357766-B5DBDFCD-28B0-4EAC-AEFA-2B081EF7DF8CQ36488735-F4A93CB4-00BD-4C1F-A616-BF30E26459F8Q36755080-C6342B01-828D-4F75-BA1F-666F68964293Q36902377-688AE9E4-0AEC-452F-A2F0-EB65B3746E58Q37144539-248A116E-0FBC-4EF9-9F27-BCF950CE9BB1Q37241549-FB5FF3B9-AA1A-4711-911A-3152F2667119Q37245454-FBCB0599-42C8-4925-AB31-47F29447EBF6Q37265312-9D15B91D-2273-4841-9194-E6082EED95E2Q37277707-6567100F-E91C-46A9-A16E-255FD2A14585Q37623676-01BBEB42-6A5C-4B61-BC1C-88C148AB9940Q37737843-A96DFF43-359C-4EB2-AC57-7AC89FF2E5B8Q38045826-722DBEF2-B753-47FA-8FFF-D6B07C955D19Q38094071-047B0A2F-AA43-42CB-9EE6-002EBC17C8D9Q38463698-CB146EEA-AD9E-4783-9F4D-4CB6C9B7B2F2Q38676246-5F1FF0F2-0529-46DE-99C9-671730859C28Q38924990-8BCBF60F-C056-4103-91F4-AC7AD27EBC3AQ39294630-37F85F23-F620-4754-8FA6-80A72CB7E2BC
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Francis Mccormack
@ast
Francis Mccormack
@en
Francis Mccormack
@es
Francis Mccormack
@nl
Francis Mccormack
@sl
type
label
Francis Mccormack
@ast
Francis Mccormack
@en
Francis Mccormack
@es
Francis Mccormack
@nl
Francis Mccormack
@sl
prefLabel
Francis Mccormack
@ast
Francis Mccormack
@en
Francis Mccormack
@es
Francis Mccormack
@nl
Francis Mccormack
@sl
P106
P1153
7006724397
P21
P31
P496
0000-0001-7168-9464